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Abstarct
Background: A recent review estimated prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in
healthcare workers (HCWs) to be 4.6%. However, MRSA carriage in HCWs in non-outbreak settings is thought to be
higher than in an outbreak situation, due to increased hygiene awareness in outbreaks, but valid data are missing.
The goals of this paper are to summarise the prevalence of MRSA carriage amongst HCWs in non-outbreak situations
and to identify occupational groups in healthcare services associated with a higher risk of MRSA colonisation.
Methods: A systematic search for literature was conducted in the MEDLINE and EMBASE databases. The
methodological quality of the studies was assessed using seven criteria. Pooled prevalence rates were calculated.
Pooled effect estimates were identified in a meta-analysis.
Results: 31 studies were included in this review. The pooled MRSA colonisation rate was 1.8% (95% confidence
interval [CI], 1.34%-2.50%). The rate increased to 4.4% (95% CI, 3.98%-4.88%) when one study from the Netherlands
was excluded. The pooled MRSA rate was highest in nursing staff (6.9%). Nursing staff had an odds ratio of 1.72
(95% CI, 1.07-2.77) when compared with medical staff and an odds ratio of 2.58 (95%, 1.83-3.66) when compared
with other healthcare staff. Seven studies were assessed as being of high quality. The pooled MRSA prevalence in
high quality studies was 1.1% or 5.4% if the one large study from the Netherlands is not considered. The pooled
prevalence in studies of moderate quality was 4.0%.
Conclusions: MRSA prevalence among HCWs in non-outbreak settings was no higher than carriage rates
estimated for outbreaks. Our estimate is in the lower half of the range of the published MRSA rates in the endemic
setting. Our findings demonstrate that nursing staff have an increased risk for MRSA colonisation. In order to
confirm this finding, more studies are needed, including healthcare professionals with varying degrees of exposure
to MRSA. In order to reduce misclassification bias, standardisation of HCWs screening is warranted.
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Background
Methicillin-resistant Staphylococcus aureus (MRSA) is
the most commonly identified antimicrobial-resistant
pathogen in hospitals in many parts of the world [1]. In
Europe, the proportion of methicillin resistance in strains
of Staphylococcus aureus (S. aureus) isolates in infected
patients varied in 2011 from less than 0.5% to more than
50%, with a pooled mean rate of around 17% [1]. In the
United States, the proportion of methicillin resistance
in S. aureus strains approached almost 60% in 2003,
with an average rate of resistance over the period 1998–
2002 of around 50% [2]. In several European countries,
a reduction in the proportion of bloodstream infections
caused by MRSA has been observed, which may reflect
the success of infection control measures in the clinical
setting [3]. Nevertheless, the burden of healthcare-
associated MRSA colonisation seems to extend beyond
the clinical setting to long-term care facilities and out-
patient care [4].
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The anterior nares are the main reservoir of MRSA, al-
though other body sites are frequently colonised, such as
the hands, skin, axillae, and intestinal tract [5,6]. Colonised
individuals are generally asymptomatic and three types of
MRSA carrier status can be distinguished: non-carriers,
persistent carriers, who are chronically colonised with the
same strain, and intermittent carriers, who are colonised
with varying strains for short time periods [6]. A special
form of short-term carriage is transient carriage, which is
identified during or after a work shift and in most cases
lost before the next shift [7]. Nasal carriage of S. aureus
has been associated with an increased risk of infection for
the colonised individual [8], and a similar increased risk is
expected for intestinal carriage [5]. However, it is unclear
whether the risk of infection is higher for the colonised in-
dividual when carriage is persistent [9,10]. Approximately
5% of colonised HCWs develop clinical infections [6] and
symptomatic MRSA infections among HCWs have been
described in several case reports [11,12].
Healthcare workers (HCWs) are likely to be important
in the transmission of MRSA, but more frequently act
as vectors, rather than being the main sources of MRSA
transmission [6,13,14]. The most important mode of
MRSA transmission is through contamination of the
hand [15]. An alternative mechanism of transmission is
airborne dispersal of staphylococci in association with
an upper respiratory tract infection [16]. Colonised
HCW are most often transiently colonised, but they
may become persistent carriers if they have chronic
dermatitis or sinusitis, and this may lead to prolonged
MRSA transmission [17,18].
Whilst routine screening of all potential inpatients at
risk is receiving increasing political support, the proce-
dures of screening and decolonisation for colonised
HCWs remain controversial [6,13]. Although in regions
with low MRSA prevalence, such as the Netherlands,
screening after each contact with MRSA-positive patients
is recommended [19], the guidelines of several European
countries and North American health associations are
more reluctant and only advocate staff screening in se-
lected situations, such as epidemiological outbreaks
[17,20-22]. Decolonisation of nasal colonised HCWs
with mupirocin is recommended by most guidelines,
but critical questions have arisen about the systematic
use of this antibacterial agent [23]. Other issues related
to the management of colonised HCW have been raised in
the literature, including the questions of the optimum tim-
ing of HCW screening and whether and for how long
colonised HCWs should be excluded from work [6,13].
Work restrictions for HCWs colonised with MRSA differ
geographically, ranging from being allowed to work with-
out restrictions other than compulsory hand hygiene, to
being removed from clinical duties or being forced to take
leave of absence [6].
In German speaking countries, active post-exposure
screening of HCWs is not routine [21,24,25]. In the case
of persistent carriers, further employment of the employee
is not advised where there is patient contact. The German
Code of Social Law (SGB VII, Art 9, §3) does allow the
recognition of an infection with MRSA as an occupational
disease, however colonisation with MRSA without signs of
infection cannot be recognised and compensated for as an
occupational disease. HCWs with MRSA colonisation
might therefore suffer from job restrictions without being
covered by the social accident insurance.
The prevalence of MRSA colonisation among HCWs was
assessed in two reviews to be around 5%, on the basis of
127 papers published between 1980 and March 2006 [6]
and a further 18 papers published between April 2006 and
March 2010 [13]. Both reviews included worldwide MRSA
data from endemic situations and outbreaks. Aside from
outbreaks, it is assumed that MRSA rates will be higher
when HCWs comply poorly with hand hygiene and contact
precautions, as they are not fully aware of the threat of the
bacteria load [6]. However, only a few data are available on
the prevalence of MRSA carriers among HCWs in non-
outbreak settings. The goals of the present review were to
document the prevalence of MRSA carriage amongst
HCWs in non-outbreak settings in European countries and
the United States and to identify occupational groups and
specialties in the healthcare services associated with a
higher risk of MRSA exposure.
Methods
Search strategy and screening
The systematic review was conducted according to the
PRISMA statement [26]. We searched MEDLINE and
EMBASE for articles published between January 2000 and
December 2013. Search terms and Medical subject Head-
ings (MeSH) for Methicillin-resistant Staphylococcus aur-
eus and health personnel were combined with two
searches relating to prevalence and screening as follows:
 Methicillin-Resistant Staphylococcus aureus OR
MRSA
AND
 Health personnel OR healthcare worker$ OR
healthcare professional$ OR staff OR employees
AND
 Prevalence OR cross-sectional study OR carrier state
OR carriage
AND
 Screening OR screen OR surveillance
The results of the search were limited to studies in
human and to articles written in English, German, Spanish
or Italian. The titles and abstracts identified by the search
were screened by MD and at least by one of the other
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authors and relevant papers were selected for the review.
Full-text evaluation was conducted by MD and in case of
uncertainty, discussion took place with the other authors.
Articles were included if they reported prevalence rates
of MRSA in personnel working in healthcare settings in
European countries or the United States. We restricted our
search to studies carried out in European countries and the
United States, as the situation in healthcare settings in these
countries can be compared directly. Prospective (cohort)
studies were included if baseline data were presented for
the whole study population. Articles were excluded if they
were related to outbreaks, to patients or residents only,
were not performed in Europe or in the United States,
or were designed as an incidence study. Bibliographies
of included studies were also reviewed to retrieve any
further references. Results were not limited to peer-
reviewed publications, e.g., Letters to the Editor and ab-
stracts of conference publications were also included.
A data extraction form was developed to collect infor-
mation on the following points: 1) study design (country,
study period, sample size, study population, and health-
care setting); 2) swabbing methods (anatomic sampling
sites and screening strategy); 3) results (number and per-
centage of subjects colonised with MRSA and percentage
of MRSA carriage related to occupational groups or
specialty); and 4) study quality.
As we conducted a review of existing literature no ap-
proval of an ethics committee was required.
Assessment of study quality
The quality of included papers was independently assessed
by two authors (CP and AS), using a tool composed of
seven criteria taken from a checklist aimed at evaluating
the quality of prevalence surveys [27] and the STROBE
statement [28]. The criteria were expressed as questions
(Table 1). The answers were graded as Yes (with a score of
one point) if the question was satisfactorily answered,
otherwise with a score of zero points if information
was missing (not documented) or unclear. Study qual-
ity was assessed as high (>4 points) or moderate (≤4
points).
Statistical analysis
Studies were grouped according to the quality level (high
and moderate), study area (United States and Europe),
and occupational group (nursing staff, medical staff and
other healthcare staff ). The pooled prevalence of MRSA
colonisation was calculated by dividing the number of
MRSA-colonised subjects by the total number of sub-
jects for whom culture results were reported. Carriage
rates were described by 95% confidence intervals of pro-
portions. Studies which reported stratified numerator
and denominator data for occupational groups were in-
cluded in the meta-analysis. The proportion of subjects
in two occupational groups (nursing and medical staff )
was compared with the group of other healthcare staff
and with each other. These data were used to calculate
odds ratios (OR) as effect estimates and 95% confidence
intervals (95% CI). For the purpose of meta-analysis, a
combined effect estimate was calculated using the
Mantel-Haenszel method for dichotomous outcomes.
Odds ratios were stratified for study area and study
quality. χ2 analysis was used to compare proportions
and to determine heterogeneity among studies. As the
χ2 test has a low sensitivity for detecting heterogeneity
in the situation of a meta-analysis when studies have a
small sample size, P value of < .1 was considered sig-
nificant for the presence of statistical heterogeneity
[29]. In case of homogeneity, we used a variance ap-
proach with a fixed effect model and in case of heteroge-
neity we used the random effect model [29]. Publication
bias due to study size was assessed by a funnel plot [30].
The analysis was carried out using Review Manager
(RevMan 5.1).
Table 1 Checklist for the quality assessment of MRSA prevalence surveys in healthcare workers
Number Criteria* Content
1 Specification of the target population Are study subjects and the setting described?
2 Adequate sample size** Is the sample size adequate?
3 Adequate response rate Is the response rate adequate - at least 60%?
4 Information on non-responders Are the non-responders described?
5 Valid and repeatable disease definition Are standard measures (microbiological and molecular typing methods) used
for detection of MRSA?
6 Bias Are efforts described to address potential sources of bias and/or have potential
sources of bias been discussed?
7 Interpretation of the results Were confidence intervals or standard errors presented for the estimates of prevalence?
*Criteria adopted from [27,28].
**Calculation of adequate sample size was based on the following assumptions: prevalence rate of MRSA in healthcare workers = 5%, error rate ±2.5 at the 95%
confidence level, resulting in a sample size of 284; we considered a final sample size (after subtracting the non-responders) to be of 250.
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Results
Studies identified and assessment of study quality
The database search identified 195 unique papers (Figure 1).
A total of 166 papers were excluded, because data of
MRSA rates were collected outside Europe or the United
States (n = 32), were collected during outbreaks (n = 19),
belonged to patients or residents only (n = 25), or because
the topics of these papers were reviews or guidelines or
focused on other subjects (incidence studies, cost calcu-
lations, MRSA associated with livestock or communities)
(n = 90). Twenty nine papers were eligible for full-text
evaluation, of which 21 were included. An additional ten
papers were identified via reference screening. Thus, a
total of 31 papers were included in the review (Table 2).
After consideration of the seven quality criteria, the
quality level was assigned as “high” in seven studies
[31-37] and as “moderate” in 24 studies [38-61]. Six of
the 31 studies included were based in the United States
and 25 in Europe, conducted in eight different countries
(France, Germany, Ireland, Italy, Portugal, Spain, the
Netherlands and the United Kingdom). Sample size
ranged from 13 to 13,195, with a median sample size per
study of 200 HCWs (interquartile range, 126–335). A
variety of professions were included as participants (e.g.
nurses, care assistants, physicians, paramedics, domestic
staff, cleaning staff, kitchen staff and administrative staff ).
Study participants worked in around 14 different special-
ties. Around 60% of the studies (n = 18) were conducted
in acute care hospitals, eight studies in long-term care
facilities for the elderly, and one study in medical
microbiology laboratories. Four studies were conducted
in a non-clinical surrounding such as conferences
[42,43,54,61]. All studies performed screening by nasal
swabbing; some studies used additional sampling sites.
243 records identified through database search
157 from EMBASE, 86 fromMedline
195 records after duplicates
removed
195 records screened
166 records excluded after
title-abstract selection
based on eligibility criteria
8 full-text articles excluded
based on eligibility criteria





29 full-text articles assessed
for eligibility
Figure 1 Study-selection process for this review. PRISMA flowchart.
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Table 2 Studies reporting methicillin-resistant Staphylococcus aureus (MRSA) colonisation in healthcare workers (HCWs) in non-outbreak situations in Europe












Screening strategy No. (%) of subjects
with MRSA
Related to occupation or










563 Nurses, care and domestic
assistants, kitchen and
clerical staff; nursing
home (n = 45)
Nose On one day in each
nursing home
43 (7.5) Nurses 8.7 1:Y; 2:Y;
Care assistants 10.2 3:Y; 4:N;

















night, day & mid-day
shifts
17 (6.6) Nurses/ther. 10.5 1:Y; 2:Y;
Physicians 3.8 3:N; 4:N;















Nose ND 60 (6.2) Nursing 9.6 1:Y; 2:Y;
Medical 6.3 3:Y; 4:N;










The Netherlands 266 Employees; medical
microbiology
laboratory (n = 5)












Nose Once a month 4 (2.0)c 1:Y; 2:N;
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(n = 5 (emergency
departments)
Nose Swabs taken at the
beginning of the shift
11 (4.3) Nursing/medical 1:Y; 2:Y;
technicians 6.9 3:N; 4:N;






The Netherlands 13.195 HCWs involved in the























Nose 3 screening sessions
per year
6 (4.8)c Nurses 8.9 1:Y; 2:N;
Nurse aids 4.4 3:Y; 4:N;




ND Germany 13 Nursing staff;
LTCF-E (n = 2)












Nose ND 14 (2.5) Students 2.4 1:Y; 2:Y;







US, Chicago 105 Nurses, physicians,
technicians; hospital
(emergency department)
Nose Swabs taken during
the shift at times
convenient to
the subjects
16 (15.0) Nurses 17.0 1:Y; 2:N;
Physicians 8.0 3:N; 4:N;






France 152 Physicians, paramedical
HCWs; attendees of
a medical conference
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260 Surgical and non-surgical
physicians (phys.);
attendees of a medical
conference (n = 2)

















Nose Twice a year
as far as possible








Spain 62 HCWs involved in treat-ment
of MRSA-positive patients;
hospital; (ICU in an
institute of oncology)








Germany 64 Staff members; nursing
home (n = 8), geriatric
clinic (n = 2)












Germany 158 Staff members; nursing
home and geriatric
rehabilitation unit












Nose ND 30 (12.0) Nurses 12.0 1:Y; 2:Y;
Physicians 13.0 3:N; 4:N;






Germany 324 Nurses and physicians
involved in the treatment
of MRSA-positive patients;
hospital (trauma unit)
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Germany 447 Nursing and medical
staff); hospital (ICU
and general ward)
Nose, oro-pharynx Episodal staff
screening
3 (0.7) Nursing 0.8 1:Y; 2:Y;
Medical 0.0 3:N; 4:N;






Italy 69 Nurses, physicians and
other staff; LTCF-E (n = 5)
Nose, oro-pharynx,
inguinum








Italy 51 Staff members;
nursing home








Germany 193 Nursing staff; nursing
home (n = 61)














Nose Swabs taken by
HCWs them-selves
during the congress
1 (0.3) Physicians 0.5 1:Y; 2:N;









Nose Swabs taken at
the beginning
of the shift
3 (1.5) Nurses 1.6 1:Y; 2:N;























































Table 2 Studies reporting methicillin-resistant Staphylococcus aureus (MRSA) colonisation in healthcare workers (HCWs) in non-outbreak situations in Europe
and The United States (Continued)
Sassmannshausen
2011 [58]

















France 193 Nursing staff, physicians,
physical therapists, office
staff; geriatric wards
(acute medical care and
long-term care units)






















ND France 565 Physicians (phys.);
attendees of medical
conferences in France










aAbbreviations: ICU intensive care unit, LTCF-E long-term care facility for the elderly, ND not documented.
bDetails for criteria see Table 1.
cData related to the baseline screening.
dData related to the total study period (with repeated screening surveys).
ePositive on two consecutive swabs.




















Swabs were collected by research assistants except for
two studies, in which swabs were taken by the HCWs
themselves [34,54]. The screening strategy with regard
to the timing of the swabbing was described by five
studies [32,36,41,55,57]. Two studies presented data
collected by routine screening [37,56].
A total of 21,289 subjects were included in the review.
MRSA colonisation was identified in 388 of the HCWs
swabbed, corresponding to a pooled prevalence of 1.8%
(95% CI, 1.34%-2.50%). The carriage rate within the individ-
ual studies ranged from 0.2% to 15%. When the large study
from the Netherlands [37] was excluded from the analysis
(because more than 60% of subjects included in the review
were supplied by this study), the pooled MRSA prevalence
among the remaining 8,094 HCWs increased to 4.4% (95%
CI, 3.98%-4.88%). The pooled MRSA prevalence among
HCWs in Europe was 1.5% (or 4.0% when the study from
the Netherlands was excluded) and was significantly lower
than the value estimated for HCWs in the United States
(p< 0.001), with a pooled prevalence of 6.6% (95% CI,
5.35%-8.17%). The pooled MSRA prevalence among HCWs
screened in a non-clinical surrounding was 3.1% (95% CI,
2.24%-4.13%).
It was not possible to pool MRSA data for different spe-
cialties, as only a few papers focused on the same spe-
cialty. For specialities covered by at least three papers, the
ranges were as follows: 0.5% to 36.0 for long-term care fa-
cilities for the elderly [31,33,39,46,47,51-53], 1.6% to 5.1%
for intensive care units [32-34,45], and 4.3% to 15.0% for
emergency departments [32,36,41].
The pooled MRSA prevalence among HCWs from the
high quality studies was 1.1% (95% CI, 0.66%-1.74%) and
was significantly lower than among HCWs from methodo-
logically moderate studies (p < 0.001), with a pooled preva-
lence of 4.0% (95% CI, 3.47%-4.50%). When the study
from the Netherlands was excluded, the pooled MRSA
prevalence among HCWs from high quality studies in-
creased to 5.4% (95% CI, 4.61%-6.39%).
The meta-analysis of all studies reporting MRSA preva-
lence rates for nursing staff (n = 8) showed that the risk of
MRSA colonisation was 2.58 times higher than for other
healthcare staff; the χ2 test showed no evidence of hetero-
geneity (Figure 2). Visual examination of the funnel plot
to assess publication bias revealed no systematic relation
between study size and the magnitude of the estimator
(funnel plot not shown). When all high quality studies
were pooled, the risk for nursing staff was even more pro-
nounced than for other staff (OR 3.66). Nursing staff had
an odds ratio of 1.72 when compared with medical staff
(Table 3). Stratified analysis by study area showed that in
Europe risk of MRSA colonisation was three times higher
for nursing staff than for other healthcare staff (OR 3.19),
whereas studies conducted in the United States provided
no evidence of greater risk (Table 3).
Discussion
This review incorporated 31 studies on MRSA prevalence
rates among HCWs in Europe and the United States. Only
studies conducted in a non-outbreak setting were in-
cluded. The pooled prevalence of MRSA colonisation
among HCWs was estimated as 1.8%. When the study of
Vos et al. [37] reporting data of routine screening from
the Netherlands was excluded, pooled prevalence in-
creased to 4.3%. This estimate is slightly lower than the re-
sult of a previously conducted review, which estimated the
average MRSA carriage rate among HCWs as 4.6% [6].
Bearing in mind that estimates of Albrich and Harbarth
[6] were based on worldwide data and in a variety of en-
demic and outbreak settings, the similarity between the re-
sults is surprising. The authors themselves pointed out
that the studies on endemic settings and outbreaks were
quite heterogenous [6], so that direct comparison does not
appear appropriate. We believe that the methods used in
non-outbreak studies included in our review permit a
more valid estimation of MRSA prevalence, than studies
performed during outbreaks which usually focus on the ef-
ficacy of the measures taken. Our estimate should be com-
pared with published values in the endemic setting. It is
towards the lower end of the range of 2% to 15% given in
[13] and about half the value of 8.1% estimated by [6].
Our review has shown that MRSA carriage in HCWs var-
ies widely over a range between under 1% and 15%. Car-
riage rates among HCWs are much higher than among
community members without known risk factors (around
0.2% [62]). MRSA carriage was higher among HCWs in the
United States than in Europe but carriage was not as high
as could have been expected, if it is considered that the pro-
portion of methicillin-resistance of S. aureus isolates in in-
fected patients is three times higher in the USA than in
Europe (60% vs. 20%) [1,2]. Within Europe, there is a north
to south gradient, with less than 1% invasive MRSA infec-
tions in northern Europe and more than 25% in southern
and south-eastern Europe [1]. Our data cannot be used to
confirm this gradient for HCWs, as there are few studies
from countries with very low or very high prevalence. In
Italy, the MRSA prevalence in patients is between 25% and
50% [1], and MRSA carriage rates in HCWs varied between
1.5% and 14.5% (n = 3 studies).
Although study participants were in a variety of oc-
cupations, occupation-related carriage rates combined
with absolute figures were reported in fewer than 10
studies and only for nurses and physicians. We found
significantly elevated risks for nursing staff. According
to our data, the risk for nursing staff of being colonised
with MRSA was almost two-fold higher than for med-
ical staff and three-fold higher than for other health-
care staff. To our knowledge, this comparison of
pooled MRSA prevalence data between nursing and
medical staff has not been conducted in other studies.
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Our finding is concordant with previous studies
[32,38,41] and can be explained by the more frequent
and close contact of nurses with patients than for other
healthcare professionals. Other studies have reported
poor associations between profession and MRSA car-
riage rate [33,48].
With regard to high risk units, the mean proportions
of MRSA are apparently higher in staff working in
emergency departments, though no significant trend
was observed. It is unclear from our data whether non-
clinical settings such as nursing homes or neurological
rehabilitation units can be regarded as high risk units
with regard to MRSA exposure for staff. But in
Germany, a large proportion of claims to the compensa-
tion board for MRSA infections are made by nursing
staff from nursing homes for the elderly [12].
The methodological quality of the studies was quite
inconsistent with respect to sample size, response rate
and efforts to address potential sources of bias. Only
seven studies were assessed as being high-quality stud-
ies. Pooled MRSA carriage rate was higher among
HCWs from high quality studies than for moderate-
quality studies. There is no apparent explanation for
this observation.
Levels of staff MRSA carriage in published studies are
generally difficult to interpret. The most important rea-
sons for misclassification are sampling site, and the fre-
quency and timing of HCW screening [6,13]. Only the
anterior nares were used as sampling sites in most stud-
ies, this could lead to underestimation of the true preva-
lence of MRSA carriage. The reliability of the result
could also have been affected if the nasal samples were
taken by different staff members, rather than just by
one trained study assistant. The timing of the screening
test will have an important influence on the results ob-
tained, as MRSA colonisation is often transient - as has
been shown by several prospective cohort studies
[7,33,59]. As nasal samples were collected at a single point
of time in almost all studies included and in most cases at
times convenient to the subjects during or after their work
shift, no distinction between transient or persistent car-
riage is possible [6]. The question, whether swabs taken
from HCWs outside their clinical environment might be
more representative of the prevalence of persistent MRSA
carriage status, cannot be answered by our data.
Routine staff screening for MRSA is highly conten-
tious [63]. Opponents of routine staff screening argue
that there is no proof of its benefit [43], that there is a
Table 3 Pooled estimates of MRSA colonisation among healthcare workers: stratified analysis
Stratified analysis [sets of studies] Number
of studies
Pooled estimation Heterogeneity
OR 95% CI Χ2 p value
Nursing staff versus medical staff [32,33,36,38,41,48,50,55] 8 1.72 1.07-2.77 4.60 0.71
Nursing staff versus other healthcare staff
- high-quality studies [31-33,36] 4 3.66 2.33-5.77 1.18 0.76
- study area Europe [31,33,38,50,55] 5 3.19 1.98-5.13 1.26 0.87
- study area US [32,36,41,48] 4 2.07 0.83-5.15 6.4 0.09
Figure 2 Forest plot showing the risk of MRSA colonisation for healthcare workers. Block with line = Odds ratio with 95% CI. For convenience
reasons only the first author of the study is given.
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risk of stigmatisation of those affected and that reliable
evidence is limited on the effectiveness of staff screen-
ing for the prevention and control of MRSA in an en-
demic setting [13].
Limitations
Most studies included in this review achieved only a
moderate quality level. This is partly explained by our
search strategy. Our review was not limited to peer-
reviewed publications, as otherwise many studies would
have been missed [34,39,40,47,52,56,58,61]. Due to the
nature of the publications, it was not always clear
whether the reporting of the study or the study itself
had shortcomings. Even with this consideration, the
number of good quality studies was surprisingly small.
All conclusions drawn from our review should therefore
be regarded with scepticism.
Conclusions
We found that MRSA prevalence among HCWs in non-
outbreak settings was no higher than carriage rates esti-
mated for outbreaks. Our estimate is in the lower half of
the range of the published MRSA rates in the endemic
setting. More attention should be given to the preven-
tion of MRSA colonisation in nursing staff, as this pro-
fessional group seem to experience the highest risk for
MRSA colonisation. Better standardization of screening
strategies of HCWs is needed, as sampling site, fre-
quency and timing of HCW screening are the most im-
portant reasons for misclassification.
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